Glucocerebrosidase (GBA) heterozygous variants are the most important genetic risk factor for the development of Parkinson’s disease (PD) and Dementia with Lewy Bodies (DLB) (i.e., alpha-synucleinopathies) [1]. The gene discussed is GBA1; the disease is Parkinson disease.